FAQ

Home  /  FAQ

What is Triradiate A.I.R.? A.I.R. is the core fully automated medical image segmentation software package developed by Triradiate Industries.
What type of scans can A.I.R. segment? Currently, A.I.R. is able to analyze CT scans of the chest, abdomen, and pelvis done with contrast.  Segmentation of studies done without contrast is more limited, though features are constantly evolving.

One of the major advantages of the Triradiate approach is that vessel tracking and organ segmenation can be achieved even when a study is done in non-arterial phases or with a missed contrast bolus.

How can I try out the Triradiate A.I.R. system? Head over to www.zebra-med.com and register to use their development platform.  The automated segmentation software is currently being integrated into their platform and will be available in the coming months.
Is the Triradiate System FDA approved and for sale in the US? A.I.R. is still under active development with ongoing research collaborations.  We are currently interested in partnering with academic and commercial institutions to further develop and test the segmentation algorithms prior to full commercial release.
How can I invest in Triradiate Industries? We greatly appreciate your interest in Triradiate Industries. We are a privately held company and are not actively seeking outside funding.Feel free to email us for more details (contact@triradiate.com)
How can I apply for a job with Triradiate Industries? Please email us at career@triradiate.com. Make sure to include your up to date resume and at least 3 current references.